One of the most active intellectual property litigators in the country and Chairperson of the firm’s Litigation Department and ANDA Litigation Team, Robert Silver represents global and U.S. companies in a wide range of litigation. His litigation practice as lead counsel for large, world-wide generic companies has emphasized complex suits involving Abbreviated New Drug Applications (ANDA) containing Paragraph IV challenges under the Hatch-Waxman Act. Mr. Silver counsels clients on ANDA preparation and strategies and has prepared, tried, argued and settled ANDA litigation cases all over the country. Mr. Silver was also responsible for assisting a generic client launch the most successful and profitable at-risk launch in history with close to $1 billion in sales made in 5 days.

Awards & Recognition

  • Who’s Who Legal: Patents 2018-2019
  • Best Lawyers in America, 2018-2019
  • Pennsylvania Super Lawyer, 2004-2018
  • Martindale Hubbell AV Preeminent Rated
  • Chambers USA Top Ranked in Intellectual Property, 2010-2016
  • Senior Fellow Litigation Counsel of America, The Trial Lawyer Honorary Society
  • IAM Patent 1000 Ranked Attorney, 2014-2019
  • Top Attorneys in Pennsylvania Philadelphia Magazine 2018
  • Best Lawyers in Pennsylvania 2019 Wall Street Journal
  • 2019 Global Law Experts IP Litigation Law Expert
  • The Actors Fund 2018 Encore Award for Performing Arts commitment
  • Trial Law Institute and Diversity Law Institute Member

Industries Served

  • Biomedical
  • Biotechnology
  • Chemical
  • Mechanical
  • Pharmaceuticals

Related Representative Matters

  • Sanofi-Aventis, Sanofi-Synthelabo, Inc., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership v. Apotex, Inc., represented generic in ANDA litigation on Plavix® involving largest at risk launch in history
  • Roxane Labs Inc. v. Invagen Inc., successfully represented defendant generic company in transferring case from Ohio to NJ, defeated Preliminary Injunction, affirmed on appeal and obtained stipulation of non-infringement, affirmed on appeal, in suit by another generic regarding calcium acetate tablets (PhosLo® brand) and ultimately awarded client $2 million in attorney fees finding the case “exceptional”
  • Genzyme v. Pentech Pharmaceuticals, Inc. represented generic in ANDA litigation on Hectorol® invalidating 2 Orange Book listed patents, with third patent being delisted as a result of suit
  • Biovail Laboratories, Inc. v. Torpharm. Inc., successfully represented generic company in ANDA litigation involving Tiazac® (diltiazem hydrochloride)

Related Posts

  • The Deepest Bench of the Best Lawyers
  • Caesar Rivise PC Receives Tier 1 Ranking in 2019 from Best Lawyers – U.S. News & World Report
  • Caesar Rivise’s Diversity Shines Through in Victory for Generic Drug Manufacturers
  • Caesar Rivise Attorneys Named to 2017 Pennsylvania Super Lawyers
  • $1.9 Million Awarded to Defendants for Caesar Rivise Attorneys’ Fees in Exceptional Case
  • Caesar Rivise Wins Motion For Attorneys’ Fees In Exceptional Case
  • Roxane Gets the Red Light from the Federal Circuit
  • CR Attorneys Named 2016 Pennsylvania Super Lawyers
  • The Court of Appeals for the Federal Circuit Finds Specific Jurisdiction in ANDA Patent Cases
  • Caesar Rivise Wins Motion to Transfer Case to the U.S. District Court for the Central District of California
  • ANDA Litigation Basics Under the Hatch-Waxman Act and Medicare Prescription Drug, Improvement and Modernization Act of 2003
  • Caesar Rivise Obtains Federal Circuit Affirmance of a Denial of a Motion for Preliminary Injunction
  • U.S. Buyers and Their Legal Advisors Beware: Indian Court’s Injunction Against Glenmark’s Continued Infringement of Symed Lab’s Process Patent Suggests That Pharmaceutical Method Claims Are Becoming More Readily Enforceable in India


  • Commonwealth of Pennsylvania
  • Supreme Court of the United States
  • United States Court of Claims
  • United States Court of Appeals for the District of Columbia Circuit
  • United States Court of Appeals for the Federal Circuit
  • United States Court of Appeals for the Third Circuit
  • United States District Court for the Eastern District of Pennsylvania
  • United States District Court for the Western District of Michigan
  • United States Patent and Trademark Office


  • B.S. Chemistry, Boston College
  • M.S. Chemistry, Boston College
  • J.D., Villanova Law School

Contact Us

Please fill out the form below and our attorney will contact you.


Our Office

  • Philadelphia Office


    1635 Market Street
    12th Floor
    Philadelphia, Pennsylvania 19103